
TNF Pharmaceuticals
Focuses on developing novel therapeutics targeting aging, autoimmune diseases, and chronic conditions.
Market cap
$4.3m
Enterprise value
$3m
Share price
$0.06 MYMD
Authorizing premium user...
Focuses on developing novel therapeutics targeting aging, autoimmune diseases, and chronic conditions.